Health Care Equipment & Services

Zeiss Meditec unveils the EVA NEXUS™ cataract configuration, adding precision‑grade presets and streamlined workflows to its retinal platform—boosting surgical control and market leadership.

Veeva’s Q2 2026 earnings hit a record 40% jump in operating income, sparking analyst target hikes to $275‑$325 and a new 52‑week high in shares.

EssilorLuxottica launches a $918 M buyback and new vision tech, boosting investor confidence while tackling the 2050 myopia crisis.

NeuroOne’s recent insider buys show exec confidence in its EEG and brain‑stimulation tech, highlighting strong growth potential in medical devices.

Pro‑Dex’s latest SEC 8‑K reveals key leadership changes, executive bonuses, and fresh growth strategy—insights for investors in the healthcare equipment sector.

VOXEL SA strengthens Poland’s diagnostic imaging market with 33 state‑of‑the‑art labs, MRI‑CT‑PET expertise, digital solutions, and a solid P/E‑backed growth outlook.

NeuroOne’s new StereoCED platform delivers brain‑tissue injections while recording EEG, a first‑of‑its‑kind breakthrough poised for human trials.

Theralase Technologies: Toronto’s laser‑therapy pioneer faces steep stock decline and a negative P/E, revealing urgent profit‑growth challenges in the health‑care equipment market.

PulseNmore’s stock plummets to $2.67, a stark drop from its $12.97 peak, revealing deep financial woes, lack of profitability, and urgent need for strategic change.

Avricore Health Inc. trades on TSX Venture, selling generic & OTC drugs. Learn how its distribution strategy drives growth amid a negative P/E and fluctuating share price.